Core Viewpoint - Iridex Corporation, a leader in laser-based medical systems for ophthalmology, will participate in the Sidoti Year-End Virtual Investor Conference on December 11, 2025 [1][2]. Company Overview - Iridex Corporation specializes in developing, manufacturing, and marketing innovative laser-based medical systems, including capital equipment and consumable probes for the ophthalmology market [3]. - The company's proprietary MicroPulse technology provides effective laser treatment while minimizing tissue damage, making it a safe option for treating sight-threatening eye conditions [3]. - Iridex's product line is utilized for treating glaucoma, diabetic macular edema (DME), and other retinal diseases, with sales occurring in the U.S. through a direct sales force and internationally via independent distributors in over 100 countries [3].

Core Viewpoint - Iridex Corporation is set to release its financial results for Q2 2025 and provide a business update on August 12, 2025, indicating ongoing developments in the company's operations and financial performance [1]. Company Overview - Iridex Corporation is a leader in the development, manufacturing, and marketing of innovative laser-based medical systems and devices for the ophthalmology market [3]. - The company specializes in products for treating glaucoma and diabetic macular edema (DME), utilizing its proprietary MicroPulse® technology for effective laser treatments [3]. - Iridex's products are distributed in over 100 countries, with sales in the U.S. conducted through a direct sales force and international sales through independent distributors [3]. Upcoming Events - A conference call will be held on August 12, 2025, at 2:00 p.m. PT / 5:00 p.m. ET for investors to discuss the financial results and business updates [2]. - Investors can access the call by dialing +1-888-596-4144 with the passcode 2197032, and a live and recorded webcast will be available on the company's website [2].